Increase in net spending and challenges in balancing healthcare budgets highlighted in AIFA's latest...
Read moreThe rise of personalised medicine is revolutionizing healthcare, prompting a re-evaluation of tradit...
Read moreScottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils...
Read moreThe German government’s proposal to keep negotiated confidential rebates was rejected by the feder...
Read moreSafety signals have sparked vital discussions on patient access to ATMPs, marking a pivotal moment i...
Read moreNew website provides regular updates on NLF's work, addresses challenges, and showcases collaboratio...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read moreProposed changes in Germany's pharma strategy suggest replacing publicly listed AMNOG rebates with c...
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read more